Related Experiment Video

Updated: May 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K

Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome

Jun Zhang1, Yang Li1

  • 1Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA 94080, USA.

Drug Discovery Today
|November 6, 2013
PubMed

Insights

Fibroblast growth factor (FGF)21 shows promise for treating diabetes and obesity by regulating metabolism. Research is advancing therapeutic development targeting FGF21 pathways and engineering strategies to improve its effectiveness.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Drug Development

Background:

  • Diabetes and metabolic conditions are global health crises with limited therapeutic options.
  • Fibroblast growth factor (FGF)21 is a key regulator of glucose, lipid, and energy homeostasis.
  • FGF21's therapeutic potential for metabolic disorders is significant.

Purpose of the Study:

  • To review recent advancements in understanding FGF21 functions, targets, and receptors.
  • To appraise current therapeutic development strategies targeting the FGF21 pathway.
  • To highlight novel engineering approaches and receptor agonist antibodies for FGF21.

Main Methods:

  • Literature review of recent scientific publications on FGF21.
  • Analysis of studies on FGF21 engineering for improved pharmacokinetics and stability.
  • Examination of research on FGF21 receptor complex agonist antibodies.

Main Results:

  • FGF21 effectively normalizes glucose, lipid, and energy balance.
  • Engineering strategies have enhanced FGF21's half-life, stability, and manufacturability.
  • Novel therapeutic approaches, including agonist antibodies, offer new treatment avenues.

Conclusions:

  • FGF21 is a promising therapeutic candidate for diabetes and obesity.
  • Ongoing research and development are expanding the therapeutic applications of FGF21.
  • Targeting the FGF21 pathway represents a significant area for metabolic disease treatment innovation.

More Related Videos

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

7.4K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.9K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K